[go: up one dir, main page]

WO1989011277A3 - Preparations antivirales a base de porphyrine et de phtalocyanine - Google Patents

Preparations antivirales a base de porphyrine et de phtalocyanine Download PDF

Info

Publication number
WO1989011277A3
WO1989011277A3 PCT/US1989/002256 US8902256W WO8911277A3 WO 1989011277 A3 WO1989011277 A3 WO 1989011277A3 US 8902256 W US8902256 W US 8902256W WO 8911277 A3 WO8911277 A3 WO 8911277A3
Authority
WO
WIPO (PCT)
Prior art keywords
porphyrins
porphyrin
phthalocyanine
phthalocyanines
antiviral compositions
Prior art date
Application number
PCT/US1989/002256
Other languages
English (en)
Other versions
WO1989011277A2 (fr
Inventor
Raymond F Schinazi
Dabney White Dixon
Luigi G Marzilli
Original Assignee
Univ Georgia
Univ Emory
Raymond F Schinazi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgia, Univ Emory, Raymond F Schinazi filed Critical Univ Georgia
Publication of WO1989011277A2 publication Critical patent/WO1989011277A2/fr
Publication of WO1989011277A3 publication Critical patent/WO1989011277A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Préparations permettant d'inhiber la réplication du virus de l'immunodéficience humaine, contenant une ou plusieurs ''porphyrines'' présentant une activité antivirale. Le terme ''porphyrines'' comprend les porphyrines proprement dites, les phtalocyanines, les chlorines, leurs dérivés métallo, ainsi que d'autres composés similaires aux porphyrines. On a découvert que des exemples de porphyrines, phtalocyanines et leurs dérivés, à charge positive, négative ou neutre, présentent une activité sélective anti-HIV qui est indépendante de la présence de la lumière.
PCT/US1989/002256 1988-05-23 1989-05-23 Preparations antivirales a base de porphyrine et de phtalocyanine WO1989011277A2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US197,764 1988-05-23
US07/197,764 US5192788A (en) 1988-05-23 1988-05-23 Porphyrin antiviral compositions
US335,499 1989-05-22

Publications (2)

Publication Number Publication Date
WO1989011277A2 WO1989011277A2 (fr) 1989-11-30
WO1989011277A3 true WO1989011277A3 (fr) 1989-12-28

Family

ID=22730670

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/002256 WO1989011277A2 (fr) 1988-05-23 1989-05-23 Preparations antivirales a base de porphyrine et de phtalocyanine

Country Status (3)

Country Link
US (1) US5192788A (fr)
NZ (1) NZ229246A (fr)
WO (1) WO1989011277A2 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0337598A3 (fr) * 1988-02-26 1991-07-03 Georgia State University Foundation, Inc. Utilisation de porphyrines et de métalloporphyrines dans le traitement de maladies causées par HIV
US5981163A (en) * 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
US5712086A (en) * 1990-05-15 1998-01-27 New York Blood Center, Inc. Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
WO1992002242A1 (fr) * 1990-07-31 1992-02-20 The Rockefeller University Utilisation de metalloporphyrines pour potentialiser la therapie contre le sida
EP0542915A1 (fr) * 1990-08-09 1993-05-26 Endocon, Inc. Systeme d'administration de medicaments multiples
WO1992017182A1 (fr) * 1991-04-03 1992-10-15 Agouron Pharmaceuticals, Inc. Procedes et composes d'inhibition de l'activite de rnase h de la transcriptase inverse
US5230998A (en) * 1991-07-25 1993-07-27 Neurath Alexander R Method for the prescreening of drugs targeted to the V3 hypervariable loop of the HIV-1 envelope glycoprotein gp 120
EP0601183A4 (fr) * 1991-08-02 1996-12-04 Meiji Milk Prod Co Ltd Medicament anti-vih.
US5371199B1 (en) * 1992-08-14 1995-12-26 Univ Pennsylvania Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor
US5817830A (en) * 1992-08-14 1998-10-06 Trustees Of The University Of Pennsylvania Pyrrolic compounds
US5599924A (en) * 1992-08-14 1997-02-04 Trustees Of The University Of Pennsylvania Electron-deficient porphyrins and processes and intermediates for preparing same
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
TW247876B (en) 1993-12-28 1995-05-21 New York Blood Ct Inc Pharmaceutical compositions for prevention or treating HIV-1 or HIV-2 infection
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
FR2723694B1 (fr) * 1994-08-19 1996-09-27 Oreal Utilisation de sels de derives cationiques de porphine comme agents photosensibilisants de bacteries de type gram-negatif
US6620805B1 (en) * 1996-03-14 2003-09-16 Yale University Delivery of nucleic acids by porphyrins
US6010890A (en) * 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same
IT1294325B1 (it) * 1997-08-14 1999-03-24 Molteni L E C Dei Fratelli Ali Zinco-ftalocianine e relativi coniugati, preparazione e uso nella terapia fotodinamica e come diagnostici
CA2309154C (fr) 1997-11-03 2010-02-16 Duke University Porphyrines substituees
CA2287056C (fr) * 1997-12-22 2000-08-15 Schering Corporation Forme posologique solide et orale, comprenant de la ribavirine, et son procede de fabrication
US20030215421A1 (en) * 1999-07-21 2003-11-20 Mcdonald John R. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
US7157418B1 (en) 1998-07-22 2007-01-02 Osprey Pharmaceuticals, Ltd. Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
IL126953A0 (en) 1998-11-08 1999-09-22 Yeda Res & Dev Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
IL144503A0 (en) * 1999-01-25 2002-05-23 Nat Jewish Med & Res Center Substituted porphyrins
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
US6403788B1 (en) 2000-07-11 2002-06-11 Eukarion, Inc. Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species
ATE464061T1 (de) * 2001-01-05 2010-04-15 Metaphore Pharmaceuticals Inc Zusammensetzungen und verfahren zur erhöhung der zytokin-aktivität und zur behandlung der hypotension assoziiert mit der verabreichung von zytokinen
ES2330728T3 (es) * 2001-01-19 2009-12-15 National Jewish Health Medicamento para proteccion en radioterapia.
WO2002098431A1 (fr) * 2001-06-01 2002-12-12 National Jewish Medical And Research Center Capteurs oxydants destines au traitement du diabete ou a etre utilises dans une transplantation ou a induire une tolerance immunitaire
WO2003057176A2 (fr) * 2002-01-08 2003-07-17 Emory University Porphyrines a activite virucide
CN1642540A (zh) * 2002-03-26 2005-07-20 东弗吉尼亚医学院 作为局部杀微生物药和避孕药的苏拉明及其衍生物
US7485721B2 (en) * 2002-06-07 2009-02-03 Duke University Substituted porphyrins
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
CA2556437A1 (fr) * 2004-02-20 2005-09-09 Robert F. Hofmann Utilisation d'une formulation therapeutique oxydative ciblee pour traiter des maladies virales
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
JPWO2006054757A1 (ja) * 2004-11-16 2008-06-05 アステラス製薬株式会社 カスパーゼ阻害剤
GB0519169D0 (en) * 2005-09-21 2005-10-26 Leuven K U Res & Dev Novel anti-viral strategy
GB0602125D0 (en) * 2006-02-03 2006-03-15 Univ Belfast Sensitizer-incorporated biomaterials
KR20160036108A (ko) 2008-05-23 2016-04-01 내셔날 쥬이쉬 헬스 알킬화 종으로의 노출과 관련된 상해를 치료하는 방법
EP3296320A1 (fr) 2012-03-08 2018-03-21 Halozyme, Inc. Facteur de croissance anti-épidermique actif de manière conditionnelle des anticorps de récepteurs et leurs procédés d'utilisation
US20150071923A1 (en) 2013-09-12 2015-03-12 Ge Wei Modified anti-epidermal growth factor receptor antibodies and methods of use thereof
WO2017161206A1 (fr) 2016-03-16 2017-09-21 Halozyme, Inc. Conjugués contenant des anticorps à activité conditionnelle ou des fragments de liaison à un antigène associés, et procédés d'utilisation
KR20200110745A (ko) 2017-12-15 2020-09-25 주노 쎄러퓨티크스 인코퍼레이티드 항 - ｃｃｔ5 결합 분자 및 이의 사용 방법
US10987329B1 (en) * 2020-04-22 2021-04-27 Nadimpally Satyavarahala Raju Combination therapy for coronavirus infections including the novel corona virus (COVID-19)
US11883376B2 (en) * 2020-04-22 2024-01-30 Nadimpally Satyavarahala Raju Viral infection treatment with 5-aminolevulinic acid

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0204989A2 (fr) * 1985-06-08 1986-12-17 ASTA Medica Aktiengesellschaft Utilisation de la pénicillamine pour le traitement des maladies d'immuno-dépression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
EP0127797B1 (fr) * 1983-06-03 1987-06-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Molécules marquées pour déterminations par immunofluorescence et procédés et produits intermédiaires pour leur préparation
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0204989A2 (fr) * 1985-06-08 1986-12-17 ASTA Medica Aktiengesellschaft Utilisation de la pénicillamine pour le traitement des maladies d'immuno-dépression

Also Published As

Publication number Publication date
NZ229246A (en) 1991-06-25
US5192788A (en) 1993-03-09
WO1989011277A2 (fr) 1989-11-30

Similar Documents

Publication Publication Date Title
WO1989011277A3 (fr) Preparations antivirales a base de porphyrine et de phtalocyanine
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
AU3830689A (en) Porphyrin and phthalocyanine antiviral compositions
CA2133963A1 (fr) Nouvelles mercaptoacetylamido pyricazo[1,2]pyridazine, pyrazolo[1,2]pyridazine, pyridazo[1,2-a][1,2]diazepine et derives de la pyrazolo[1,2-a][1,2]diazepine utilisees comme inhibiteurs de l'enkephalinase et de l'eca
EP1225168A3 (fr) Dérivés de prostaglandines pour le traitement du glaucome et de l'hypertension oculaire
CA2258548A1 (fr) Derives tricycliques substitues par phenylamino, destines au traitement des maladies hyperproliferatives
RU94046093A (ru) Производные 7-(2-аминоэтил)бензотиазолона, способ их получения, промежуточные соединения, фармкомпозиция
CA2272705A1 (fr) Derives de pyrimidines bicycliques fusionnes
CA2048110A1 (fr) Derives d'imidazopyridine et leur utilisation
AU669122B2 (en) New pyrazine derivatives, their preparation and their use
AU8083587A (en) Use of substituted 5h-pyrido-(2',1':2,3)- and 5h-thiazolo-(2',3':2,3)-imidazo 4,5-b indoles as cholinomimetic agents
WO1994019343A3 (fr) Nouvelle application des composes bis-heterocycliques et les compositions pharmaceutiques en tant qu'agents anti-inflammatoires
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
FR2713234B1 (fr) Nouveaux dérivés de la triphénodioxazine, leur préparation et leur utilisation comme pigments.
IE890076L (en) Porhpyric insecticides
AU632578B2 (en) Dibenzo (1,5) dioxocin-5-one derivatives, their use in medicaments and processes for their preparation
EP0272596A3 (en) Theophyllinemethyldithiolan and theophyllinemethyldithianyl derivates, a method for their preparation and pharmaceutical compositions in which they are included
AU519852B2 (en) Mino derivatives of pyrazolo(1,5-a)s.triazine
AU7147287A (en) Five-membered N-heterocyclic derivatives of N'-substituted-N,N'-diacylhydrazines
AU4146389A (en) New benzylidenecyclanone derivatives, their preparation process, their use as anti-oxidants and as sunscreens, cosmetic and pharmaceutical compositions containing them
AU588366B2 (en) Pyrido (1,2-a) pyrimidine derivatives, processes for preparing the same and pharmaceutical compositions for the treatment of allergic diseases containing the same
AU8127991A (en) Novel derivatives of 1-diphenylmethyl piperazine, their preparation and their use as medicaments
ATE35259T1 (de) Triazinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, welche diese enthalten.
NZ238638A (en) Imidazo-quinazoline and -quinoxaline derivatives; medicaments, methods of preparation and treatment
AU4956193A (en) Stable, highly concentrated formulations of fluorescein derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU DK FI JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU DK FI JP KR NO

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE FR GB IT LU NL SE